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We thank the editor for organizing this discussion of the article by Laber et al.
(2014) (throughout referred to as LLQPM). The authors offer an elegant solution
to the inferential problem caused by nonregularity. Our discussion will to a large
extent focus on conceptual rather than technical issues, in part because the
authors handled the technical matters so decisively and well. In so doing, we
recognize that discussion of conceptual issues was not the authors’ goal and that
the authors have written elsewhere about many of the issues we raise. Indeed,
in our own writing, we have often either ignored the issues we raise or were
unable to offer coherent solutions to them. We hope our discussion makes for
an interesting and lively interchange.
We first address the following conceptual issue. The author’s target of in-
ference is the stage one nonregular parameter β∗11 that determines the optimal
treatment strategy πdp1 at stage one of their two-stage trial. Robins (2004, Sec. 5)
first recognized that β∗11 was nonregular and offered a method for obtaining a
valid (necessarily conservative) confidence interval. However, in that section,
Robins also noted that β∗11 only determines the optimal treatment decision at
stage one for patients who will follow the optimal strategy at stage two; hence,
because of uncertainty, it is not possible to know that the optimal strategy πdp2
will in fact be followed at time two (even when we assume all the uncertainty is
attributable to sampling variability), and therefore it is unclear that β∗11 should
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be the target of inference. In light of these facts, he justified the study of infer-
ence for β∗11 because of its mathematical rather than its clinical or public health
interest. Below we will argue that, in many settings, the first stage parameter
of clinical interest is not β∗11 but rather the random parameter that determines
the optimal stage one strategy conditional on the treatment regime that one
will indeed follow at stage two. We show the estimation of this random param-
eter is a regular problem if one (i) splits the sample and chooses the regime at
stage two to be the one estimated as optimal from one half of the sample and
(ii) then estimates the aforementioned random parameter from the other half
of the data. However, we also show that if one estimates the stage one and two
regimes from the same sample, i.e. without sample splitting, then the problem
becomes irregular. We will show that the conservative interval estimator we are
led to is, interestingly, precisely the ACI interval estimator of the authors, even
though our targets of inference differ.
We then address a second conceptual issue. How should univariate stage-
specific confidence intervals be used in clinical decision making? The authors
suggest that if a confidence interval (say a 90% interval) for β∗Tt,1ht,1 includes
zero, then trialists should make no recommendation for the treatment that
should be administered at stage t to a patient with features ht,1; rather the
choice of which of the two stage t treatments under study to administer should
be left to the discretion of the treating physician. We show that this strategy
can lead to the implementation, for a sizable subset of the study population, of
a treatment regime that is apriori known, i.e. even before the data are collected,
to be nonoptimal.
In our final section, we discuss the issue of the sensitivity of indirect methods
and the insensitivity of most direct methods to model misspecification. Further
we discuss the question of whether direct methods that are insensitive to model
misspecification also suffer from nonregularity. We show that the evidence pre-
sented for the non regularity of a direct method by the authors in their appendix
A does not bear on this question, because the direct method they discuss is not
insensitive to model misspecification. None the less, the authors’ Theorem 3.3
and their subsequent toy example shows that estimation of the optimal value
function is an irregular problem, even when estimated with direct methods in-
sensitive to model misspecification.
Target of inference The authors’ target of inference is the stage one non-
regular parameter β∗11 that determines the optimal treatment strategy π
dp
1 at
stage one if the optimal strategy πdp2 were followed at stage two. In this section
we argue that the parameter of clinical interest may not be β∗11 but rather the
(random) parameter determining the optimal stage one regime given the regime
that was actually followed at stage two. Interestingly, we shall see that the au-
thors’ adaptive confidence interval also provides valid inference for this latter
parameter.
To avoid unrelated modeling issues, we will assume for now that X1, X2,
A1, A2 are each Bernoulli, Y is continuous and the models for the Q-functions






1,0 ≡ HT1,1 ≡ (1, X1) and HT2 ≡ (HT2,0, HT2,1) with HT2,0 ≡ HT2,1 ≡





for Q2(h2, a2) ≡ E[Y |H2 = h2, A2 = a2] with β∗2 the true value of β2. Recall
that among all stage two regimes π2 the optimal one is given by the dynamic






Given that a particular, possibly non-optimal, regime π2 is to be followed at
stage two, the optimal stage one regime ππ21 (h1) is given by argmaxa1 Q
π2
1 (h1, a1)








the authors’ dynamic programming solution π
dp









1 (h1, a1) the optimal stage one regime
when π2 will be followed at stage two is π
π2
















Y + (π2 (H2)−A2)HT2,1β∗2,1 −A1HT1,1βπ21,1
}]
= 0 (0.1)
Note that the stage one parameters must be labelled by the stage two regime
π2 as the function Q
π2
1 (h1, a1), and thus β
π2,∗
1 , varies with π2. The authors’





Consider the following parable presented by one of us at a conference in
Bristol England in 2012 attended by Susan Murphy and ourselves. You are told
the regime π2 that will be used to assign treatment at stage two. Your job is
to decide, from the data on the n subjects available to you, the best stage one
treatment for a patient with features h1. To do so you will estimate β
π2,∗
1,1 with
a semiparametric efficient estimator β̂π21,1 solving
Pn
[
H1,1 {A1 − Pn (A1|X1)}
[
Y + {π2 (H2)−A2}HT2,1β∗2,1 −A1HT1,1βπ21,1
]]
= 0
and then use this estimator to construct a point and interval estimator for
hT1,1β
π2,∗
1,1 [here Pn(A1|x1) is the empirical conditional mean of A1 given




if the 90% CI for
hT1,1β
π2,∗
1,1 does not contain zero; otherwise, following the authors, you leave the
treatment decision up to the patient’s physician.
Suppose, one day you suddenly learn that, unknown to you, the original data
set had been of size 2n but had been randomly divided in two and only the first
half-sample had been made available to you. You are told that the second half-
sample had been used to estimate the stage two regime π2 that you were told was
to be used in the future. Specifically, π2 was the estimate π̃
dp
2 (h2) = 1hT
2,1β̃2,1>0
of the optimal second stage regime πdp2 (h2) based on the second half of the data.
Here we use the symbol ˜ to denote an estimator calculated from the second
half of the data. If in the second half sample, π̃dp2 (h2) differed from π
dp
2 (h2)
due to sampling variability, then your targets of inference would be βπ2,∗1,1 |π2=π̃dp2










1 (h1) since it is π̃
dp
2 , rather than π
dp
2 (h2),
which would actually be followed in the second stage. As far as inference is con-




regular as π̃dp2 (h2) = 1hT
2,1β̃2,1>0
is fixed, so no random parameter value occurs
inside an indicator. In particular, n1/2{β̂π̃
dp
2
1,1 − βπ2,∗1,1 |π2=π̃dp2 } will be uniformly
asymptotically normal with mean zero conditional on the second sample data.
Furthermore standard 1−αWald type confidence intervals for the (conditionally
fixed) parameter βπ2,∗1,1 |π2=π̃dp2 centered at β̂
π̃dp
2
1,1 will have asymptotically correct
conditional coverage uniformly over the parameter space. This implies that this
Wald interval will provide correct unconditional coverage of the random param-
eter βπ2,∗1,1 |π2=π̃dp2 . We emphasize that unconditionally, it is the random variable







these intervals would provide uniformly correct coverage.
Consider the implication of this parable for the more typical setting in which
both the first and second stage regime are estimated from the same data. Obvi-
ously, our philosophical conclusion that we should optimize our stage one regime
in light of the regime that will actually be followed at stage two cannot depend
on whether or not we split the sample. Thus, our target of inference should re-
main the random regime ππ21 (h1)|π2=π̂dp2 just as in the split sample case, except
now π̂dp2 is the stage two regime estimated from the entire sample.
Conditional inference given π̂dp2 and, in particular, the construction of confi-
dence intervals that cover hT1,1β
π2,∗
1,1 |π2=π̂dp2 with probability (1−α) in the subset
of hypothetical repetitions with the same π̂dp2 does not appear to be doable. This
difficulty arises because of the dependence between π̂dp2 and β̂
π̂dp
2




1,1 − βπ2,∗1,1 |π2=π̂dp2 does not even converge to 0 in probability condi-
tional on π̂dp2 .
Although less desirable, unconditional inference about the random param-
eter βπ2,∗1,1 |π2=π̂dp2 is feasible. Interestingly, we will now show that the adap-
tive confidence intervals proposed by the authors cover the random parameter











































= S1,n + Σ̂
−1
1,1Pn [H1,1 {A1 − Pn (A1|X1)}Un]
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1 (h1, a1) is saturated, the estimator β̂
π̂2
1,1 coincides with the Q-learning esti-
mator β̂1,1 of LLQPM, and S1,n is the second component of the 2× 1 vector Sn




β̂1,1 − βπ2,∗1,1 |π2=π̂dp2
}
= S1,n + Σ̂
−1























The following Lemma (proved in the Appendix) extends Theorem 4.1 of
LLQPM for the special case considered here: i.e. X1 and X2 binary and the
models for the Q-functions saturated. We conjecture however that, under the
conditions of Theorem 4.1., the Lemma is valid for arbitrary covariates X1 and
X2 and linear, not necessarily saturated, models for the Q-functions.
Lemma. Suppose X1, X2, A1 and A2 are binary and P (A1|X1) = 1/2. Suppose
for each n, the underlying generative distribution Pn satisfies (A3) of LLQPM.
For any stage two regime, let βπ2,∗1,1,n denote the solution to (0.1) with β
∗
2,1 replaced







T be the random vector defined in




1,∞) where S1,∞ is of dimension
2 and for any given fixed c ∈ R4, let U(c) and L(c) be as defined in section 4.2
of LLQPM,
1) the limiting distribution of
√




























































































































3) Let c∗1 =(0, 0, c
T





































and the limiting distribution of
√




































The Lemma establishes that under the local generative process Pn the limit-
ing law of
√
n{β̂1,1 − βπ2,∗1,1,n|π2=π̂dp2 } is different from that of
√
n{β̂1,1 − β∗1,1,n}.
None the less the sharp bounds for the limit random variables are the same.
By part (3) of the Lemma,
Pn
(
cT1 β̂1,1 − U (c∗1) /
√
n ≤ cT1 βπ2,∗1,1,n|π2=π̂dp2 ≤ c
T




= 1− op (1)
Arguing as in section 4.2 of LLQPM, we thus conclude that if û1 is the (1 −
α/2)×100 percentile of the bootstrap distribution of U(c∗1) and l̂1 is the α/2×100
percentile of the bootstrap distribution of L(c∗1), then under assumptions (A1),
(A2) and (A4) of LLQPM,
PM
(
cT1 β̂1,1 − û1/
√
n ≤ cT1 βπ2,∗1,1,n|π2=π̂dp2 ≤ c
T




≥ 1− α+ oP (1)
where the inequality is an equality if P (HT2,1β
∗
2,1 = 0) = 0.
We therefore see that the confidence interval (cT1 β̂1,1−û1/
√
n, cT1 β̂1,1− l̂1/
√
n)














1,1,n|π2=π̂dp2 , the availability of the formula for the limit laws of
U(c∗1) and L(c∗1) offers the opportunity to use a semi-parametric, rather than
the non-parametric, bootstrap to approximate the quantiles of U(c∗1) and L(c∗1).
Specifically, one might consider replacing û1 with ũ1, the (1 − α/2)× 100 per-
centile of the distribution of u
(sb)
n (c∗1; S1,∞,V∞) and replacing l̂1 with l̃1, the










































































are regarded as fixed, i.e. non-random functions of s and v. We conjecture
that under assumptions (A1), (A2) and (A4) of LLQPM, the interval (cT1 β̂1,1 −
ũ1/
√





cT1 β̂1,1 − ũ1/
√
n ≤ cT1 βπ2,∗1,1 |π2=π̂dp2 ≤ c
T








cT1 β̂1,1 − ũ1/
√




≥ 1− α+ oP (1)
where the inequalities in the two preceding displays are equalities if P (HT2,1β
∗
2,1 =
0) = 0. One advantage of the semiparametric bootstrap approach is that the
Monte-Carlo approximation to l̃1 and ũ1, unlike the MC approximation to l̂1
and û1, does not require recalculating the estimators of β2,1 and β1,1 in each
Monte-Carlo draw.
Incoherent decision making based on examining univariate confidence
intervals In the discussion of the ADHD study, the authors display in ta-
ble 9 univariate confidence intervals for hTt,1β
∗
t,1 for each possible value ht,1 of
Ht,1, t = 1, 2. The authors argue that if a confidence interval (say a 90% inter-
val) for the effect parameter hTt,1β
∗
t,1 for a patient with features ht,1 at stage t
includes zero, then no treatment recommendation should be made by the tri-
alists; rather it is preferable that the choice of which treatment to administer
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should be left to the discretion of the treating physician. We will now show,
by example, that this use of univariate confidence intervals in decision making
can result in implementation on a sizeable subset of the patient population of a
treatment regime that is apriori known, i.e. even before the data are collected,
to be nonoptimal. We will also argue that this phenomena cannot occur if joint,
rather than univariate confidence intervals, are used in an analogous fashion.
The issue we raise here is of concern even in one stage studies, so to avoid
distracting complications we will discuss it in this simple setting.
Consider a one stage randomized study with dichotomous treatment A ∈
{−1, 1} and a single trivariate covariate X ∈ {−1, 0, 1}. Suppose that P (X =
x) = 1/3 for x = −1, 0, 1, that P (A = 1|X) = 1/2, and that it is known, based
on prior knowledge, that Y follows the linear homoscedastic model
E (Y |A,X) = ψ0 + ψ1X +A (ψ3 + ψ4X) (0.2)
with var(Y |A,X) = σ2. Note the model implies linear treatment effect modi-
fication by X, that is, the treatment effect function ∆(x) = E(Y |A = 1, X =
x)− E(Y |A = 1, X = x) is linear in x.
With a single trivariate covariate and a dichotomous treatment, there exist
only eight possible treatment regimes. For ease of reference, we write them as
tuples (a−1, a0, a1), aj ∈ {−1, 1} with the first coordinate indicating treatment
assignment to covariate x = −1, the second to covariate x = 0, and the third to
covariate x = 1. For instance, the tuple (1,−1, 1) corresponds to the regime that
assigns A = 1 to covariates x = −1 and 1 and treatment A = −1 to covariate
x = 0. For a given value of ψ, the optimal regime is πψ(X) = 2×1ψ3+ψ4X>0−1.
Figure 1 plots with the same color the regions where the many to one map
ψ → πψ takes the same value. For instance, on the region {(ψ3, ψ4) : ψ3 >
0, ψ4 > 0, ψ4 > ψ3}, the optimal regime assigns A = −1 to x = −1 and A = 1
to x = 0 and x = 1. Likewise, on the half-line {(ψ3, ψ4) : ψ3 = 0, ψ4 > 0}, the
optimal regime assigns A = −1 to x = −1, A = 1 to x = 1 and is indifferent
about treatment assignment to x = 0 (indifferent treatment assignment for a
covariate x is denoted with U in the corresponding entry of the tuple). Note
that the regime (1,−1, 1) does not appear in any region, as it is incompatible
with the assumption of linear treatment effect modification. This implies that
a data analyst that correctly postulates the linear model (0.2) a-priori excludes
regime (1,−1, 1) from the set of possible optimal regimes.
Now, let ψ̂ be the ordinary least squares estimator of ψ and let ψ∗ be the true
value of ψ. Under the assumed data generating process,
√
n(ψ̂−ψ∗) → N(0,Σ)
where Σ is the diagonal matrix with diagonal σ2× (1, 3/2, 1, 3/2). Suppose that
ψ̂tr ≡ (ψ̂3, ψ̂4) = (0.4, 1) and that σ̂2/n = 0.1 where σ̂2 estimates consistently


































Fig 1. Ellipsoid is a 90% Confidence region for (psi 3, psi 4). Values of (psi 3, psi 4) in
regions with the same colour correspomd to the same optimal treatment regime, indicated as
a tuple over the region.
Table 1





x = −1 −0.6± 0.82
x = 0 0.4± 0.518 61
x = 1 1.4± 0.82
shown in the Figure 1 is a 90% joint confidence region for ψ∗tr ≡ (ψ∗3 , ψ∗4). Ninety
percent univariate Wald confidence intervals (ψ̂3+ψ̂4x)±1.64 σ
√
(1 + x23/2)/n
for each ψ∗3 + ψ
∗
4x are given in table 1.
For x = 0 and x = −1, the confidence intervals for ψ3+ψ4x do not exclude 0,
so the authors would recommend to leave it to the doctor to decide whether or
not to treat patients with x = 0 or −1. In contrast, for x = 1, the recommenda-
tion would be to treat with A = 1. Now, suppose that such a recommendation is
implemented in a given population. Suppose that if given no indication on how
to treat patients with covariates x = 0 or x = −1, one quarter of the doctors in
the target population would choose to treat both kind of patients with A = 1,
a second quarter would choose to treat both kind of patients with A = −1,
a third quarter would treat x = 0 patients with A = 1 and x = −1 patients
with A = −1, and a fourth quarter would treat x = 0 patients with A = −1
and x = −1 patients with A = 1 .Then, effectively, each of the four regimes
(1, 1, 1), (−1, 1, 1), (1,−1, 1) and (−1,−1, 1) will have been implemented in one
quarter of the population. However, this would lead to implementing in one
quarter of the population the regime (1,−1, 1) which a priori is known not to
be optimal under any state of nature.
Now, given the 90% joint confidence region C(.9) for ψtr, the set Πop(0.9) =
{πψtr ;ψtr ∈ C(0.9)} with πψtr (x) = 1ψ3+ψ4x>0 contains the optimal strategy
πdp = πψ
∗
tr with probability at least 0.9 in large samples and cannot contain
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a regime that was known apriori to be non optimal. Thus, rather than leav-
ing the physicians the option of deciding what to administer to specific pa-
tients, we could offer them the opportunity to choose from the specific regimes
(−1,−1, 1), (−1, 1, 1), (1, 1, 1) that comprise the set Πop(0.9). With this strat-
egy we guarantee that no physician will end up implementing a regime known
a-priori to be non-optimal. Of course, this strategy may confuse a physician
who, unversed in the magic of linear models, may have a hard time grasping
that once the specific treatment option A = 1 is chosen (and consequently, re-
garded as optimal) for a patient with x = −1, the linear model implies that
only the option A = 1 can be optimal for a patient with x = 0. Univariate
confidence intervals do not encode the a priori restrictions imposed by models
on the Q-functions. In contrast, joint confidence regions for ψtr do. We note
that, as pointed out by Robins (2004, pp. 222–224), even in the multistage set-
ting, it is possible to construct valid uniform large sample confidence regions for
the vector of all treatment effect parameters by inverting tests, even if some of
the parameters are non-regular in the sense that they do not have a pathwise
derivative at certain generative laws.
One might wonder what regime the conventional decision theoretic approaches
would choose in our simple one-stage decision problem. In large samples the
Bayesian strategy that maximizes the posterior expected value would choose
the regime (0, 1, 1) associated with the MLE ψ̂tr = (ψ̂3, ψ̂4) = (0.4, 1), since the
posterior distribution for ψtr in large samples is normal with mean ψ̂tr. The
minimax regret regime that minimizes the maximum regret value and the max-
imin regime that maximizes the minimum value over all possible ψtr ∈ C(0.9)
for any alpha is also (0, 1, 1) because the set C(0.9) is an ellipse.
Sensitivity to model misspecification Q-learning and A-learning (also
known as g-estimation of optimal regime structural nested mean models) meth-
ods model the dependence of the quality function on information accrued. In
general this dependence is modelled parametrically in Q-learning and semipara-
metrically in A learning, although nonparametric fitting is also possible (Qian
and Murphy, 2011; van der Laan, 2013).
A second class of methods search for the optimal regime in a specific class
which often, but not always (see Zhao et al., 2012), is parametric (Zhang et al.,
2012). These methods first estimate the value function for each regime in the
class, and then estimate the optimal regime as the one that maximizes the
estimated value functions. When the dimension of the class is large, some authors
have proposed further modeling the dependence of the value functions on the
regimes in the class (van der Laan and Petersen, 2007; Robins et al., 2008;
Orellana et al., 2010). LLQPM refer to Q and A learning as indirect methods
and to methods that rely on estimates of the value function as direct methods.
Throughout the following discussion we assume that data are from a randomized
experiment, so that the stage-specific probabilities of treatment are known to
the analyst.
In the introduction, the authors mention the well known fact that indi-








to misspecification of the models for the quality function. This point is vividly
portrayed in the following example borrowed from Qian and Murphy (2011).
Consider a one-stage randomized study with binary treatment A ∈ {−1, 1}
and baseline covariate X uniformly distributed on (−1, 1) and suppose that
ej(x) ≡ E(Y |A = j,X = x), for j = −1 or 1 satisfies ej(x) = j × (x − 1/3)2.
In Figure 2, the parabolas are the curves ej(x), for j = −1 and 1. If larger
outcomes are preferable, then for no x is treatment A = −1 preferable to A = 1
since for all values of x, e1(x) ≥ e−1(x).
The best linear approximation to ej(x) (in the sense of minimizing mean
squared error) is the line lj(x) ≡ j4/9 − j2/3x, i.e. for j = 1 and −1, (j4/9,
−j2/3) = argmin(β0,j ,β1,j)
∫ 1
−1(ej(x) − β0,j − β1,jx)2 dx. The dashed lines in
Figure 2 are the lines lj(x), j = −1, 1. Consider Q-learning under the incorrect
assumption that E(Y |A = j,X) = β0,j + β1,jX . Suppose the method proceeds
by computing l̂j(x) = β̂0,j+ β̂1,jx, the ordinary least squares fit in the regression
of Y on X, separately in each treatment arm. As the sample size increases, l̂j(x)
converges to lj(x) and thus with probability going to 1,Q-learning leads to incor-
rectly conclude that treatment A = −1 is preferable for any x greater than 2/3.
Irregularity of direct method estimators Recognizing the sensitivity to
model misspecification of indirect methods, a number of authors (Zhao et al.,
2012; Zhang et al., 2012) have recommended that direct methods be used. In the
Appendix, LLQPM argue that even direct methods suffer from the problem of
nonregularity. While, as discussed further below, we are in agreement with this
remark we wish to point out that the argument given by the authors to support
this claim is incorrect because it misrepresents the estimators that the direct
methods use. In particular, the authors’ proof in Appendix A considers esti-
mators of optimal regimes whose consistency is only ensured when the models
for the Q-functions are correctly specified, thus defeating the purpose of direct
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methods. For this reason we question whether the method they analyze should
be referred to as a ’direct method’. Specifically, as in Appendix A of LLQPM,
let At ∈ {0, 1}, t = 1, 2, with P (At|Ht) = 1/2. Let πψ = (π1,ψ1,1 , π2,ψ2,1) de-
note the regime π1,ψ1,1(H1,1) = 1HT
1,1ψ1,1>0
, π2,ψ2,1(H2,1) = 1HT
2,1ψ2,1>0
and let
Vψ ≡ Eπψ(Y ) = 4P [Y 1(2A1−1)HT1,1ψ1,1>01(2A2−1)HT2,1ψ2,1>0] be its value func-
tion when the randomization probabilities at the first and second stage are
1/2. Direct methods are designed to provide estimators of the optimal regime
in the class N = {πψ : ψ is arbitrary}, i.e. of the regime πψopt where ψopt ≡
argmaxψ Vψ , which are consistent regardless of whether or not the models for
the Q-functions are correctly specified. Thus, if the models for the Q-functions
are correct the direct method consistently estimates the global optimal regime;
under misspecification of the Q-model the method still consistently estimates
the optimal regime in the parametric class N .
Setting aside computational difficulties, an instance of a direct method (see
Zhang et al., 2012) would be to separately estimate Vψ for each fixed ψ with
its empirical analog V̂ψ = 4Pn[Y 1(2A1−1)HT1,1ψ1,1>01(2A1−1)HT2,1ψ2,1>0] and next
to estimate ψopt with argmaxψ V̂ψ. In contrast, the method studied in Ap-
pendix A estimates ψopt with ψ̂ = (ψ̂1,1, ψ̂2,1), the estimator returned by the
two-stage algorithm in that Appendix. In particular, ψ̂2,1 converges in probabil-
ity to ψ∗2,1 = argmaxψ2,1 P [Y I(2A2−1)HT2,1ψ2,1>0]. However, ψ
∗
2,1 is not equal to
ψ2,opt if the model H
T
2,1ψ2,1 is misspecified in the sense that there is no vector
ψ2,1 for which E[Y |H2, A2 = 1]−E[Y |H2, A2 = 0] = HT2,1ψ2,1.This happens es-
sentially because P [Y I(2A2−1)HT2,1ψ2,1>0] is the mean over a subpopulation that
includes subjects that did not follow the regime 1HT
1,1ψ1,1>0
at stage one and for
these subjects the mean outcome under the stage two regime IHT
2,1ψ2,1>0
might
differ from the mean outcome of subjects that did follow the stage one regime
1HT
1,1ψ1,1>0
if the model HT2,1ψ2,1 is incorrect.
To illustrate this point consider the simple setting in which no covariates X1
and X2 are measured and A1, A2 are sequentially randomized with probabilities
P (A1 = 1) = 1/2 and P (A2 = 1|A1) = 1/2. Suppose that, unknown to the data
analyst,
E (Y |A1 = 1, A2 = 1) = 100, E (Y |A1 = 1, A2 = 0) = 60, (0.3)
E (Y |A1 = 0, A2 = 1) = 20, E (Y |A1 = 0, A2 = 0) = 80
With these values, the optimal treatment regime is A1 = 1, A2 = 1. Also,
E(Y |A1, A2 = 1)− E(Y |A1, A2 = 0) depends on A1. Suppose however that we
mistakenly assume that E(Y |A1, A2 = 1)−E(Y |A1, A2 = 0) = ψ2,1 is constant.
Unaware of our error and before we see the data, we would reason as follows.
The optimal stage two treatment is A2 = 1 if ψ2,1 > 0 and A2 = 0 if ψ2,1 < 0,
that is, π2,ψ2,1(A1) = 1ψ2,1>0. Letting E(Y |A1 = 1) − E(Y |A1 = 0) ≡ ψ1,1 we
likewise reason that the optimal stage one treatment is π1,ψ1,1 = 1ψ1,1>0.Thus
we would conclude that each of the four possible regimes (defined by the four
possible assignments to the pair (a1, a2)) are implied by some parameter vector
(ψ1,1, ψ2,1) as (ψ1,1, ψ2,1) varies over R
2.
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Suppose now the data with which to estimate the optimal regime are made
available. Consider first the direct method based on maximizing the four empir-
ical means. For a pair (ψ1,1, ψ2,1) such that ψ1,1 > 0 and ψ2,1 > 0, the empirical
mean direct method estimator V̂ψ = 4Pn[Y 1(2A1−1)ψ1,1>01(2A1−1)ψ2,1>0] is equal
to 4Pn[Y A1A2] which converges in probability to E(Y |A1 = 1, A2 = 1) = 100.
Likewise V̂ψ converges to E(Y |A1 = 1, A2 = 0) = 70 if ψ1,1 > 0 and ψ2,1 < 0
and so on. Thus, the direct method, consistently estimates the values of the
four possible regimes and consequently with probability converging to 1, picks
the optimal regime A1 = 1, A2 = 1. Consider instead the estimator studied
in Appendix A. The sample mean Pn[Y 1(2A2−1)ψ2,1>0] = Pn[Y A2]1ψ2,1>0 +
Pn[Y (1 − A2)]1ψ2,1<0 converges to P [Y A2] = P [Y A1A2] + P [Y (1 − A1)A2] =
(100+20)/4 = 30 if ψ2,1 > 0 and to P [Y (1−A2)] = (60+80)/4 = 35 if ψ2,1 < 0.
Thus, the algorithm in Appendix A returns ψ̂2,1 < 0 with probability going to
1 and consequently erroneously estimates that the optimal stage two treatment
is A2 = 0.
Incidentally, in this example we can use a higher level argument to recog-
nize that the authors estimators in Appendix A cannot be consistent under all
data generating laws. Specifically, it is well known that any estimator of Vψ
that is regular and asymptotically linear (RAL) under any data law, must be
asymptotically equivalent to an estimator of the form





+ Pn [(A2 − 1/2) r2 + (A1 − 1/2) r1]
for some constants r1 and r2. At the law (0.3), any RAL estimator of the
value of the optimal regime must therefore be asymptotically equivalent to
maxψ{V̂ψ(r1, r2)}. The authors’ estimator of the value of the optimal regime
is RAL at laws with E(Y |A1, A2 = 1)− E(Y |A1, A2 = 0) truly independent of
A1. If it were consistent for the optimal value function under any data law, then
it would have to be asymptotically equivalent to maxψ{V̂ψ(r1, r2)} for some
(r1, r2). However, this is not the case, so it cannot be consistent under all data
laws.
Our remark here is meant as an observation rather than a critique because
(a) when a concave relaxation is required to make the computations feasi-
ble, we do not know how to implement such a relaxation in two or multi
stage studies without introducing model dependence, (b) estimators of the
value function whose consistency relies solely on knowledge of the randomiza-
tion probabilities are less efficient than their model based counterparts, and
(c) even when a concave relaxation is not required as in our simple example
with no covariates, and the unbiased estimator 4Pn[Y 1A1=π11A2=π2 ] is used
to estimate Eπ[Y ], we believe, with the authors, that the estimation of the
optimal value and the associated optimal regime is not a regular problem;
for instance in the preceding example the estimator of the optimal value is
4max(Pn[Y A1A2],Pn[Y (1 − A1)A2],Pn[Y A1(1 − A2)],Pn[Y (1 − A1)(1 − A2)])
which is not a regular estimator of max{E(Y |A1 = a1, A2 = a2) : a1, a2 = 0, 1} if
the maximum is achieved at two or more of the four conditional means in the set.
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Finally, we note that in the comprehensive monograph on optimal dynamic
treatment regimes of van der Laan (2013), Theorem 2 claims that the optimal
value is a regular pathwise differentiable parameter at all laws of the model,
which includes those laws at which the optimal value is achieved at two or more
conditional means. In contrast, Theorem 3.3 of the present article by Laber et
al. implies that estimation of the optimal value function is an irregular problem
at such exceptional laws, even when estimated with direct methods insensitive
to model misspecification. We believe Laber et al’s. result to be the correct
one; Van der Laan’s proof of Theorem 2 is incorrect owing to inappropriately
applying the chain rule for differentiation to a composition of functions, one of
which is non-differentiable at any such exceptional law.
Appendix
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Under the underlying generative distribution Pn satisfying (A3) of LLQPM, by
their Theorem 4.1, part 2. we have
S1,n + Σ̂
−1











































































































































































































































































































































Proof of part (2).
Let pa1,x1,x2 ≡ Pr[A1 = a1, X1= x1, X2 = x2], g(X1, A1)≡ cT1 Σ−11,1∞H1,1(A1 −
1











]. For any r ∈ R8 let ra1,x1,x2
denote the realization of HT2,1r when A1 = a1, X1 = x1 and X2 = x2. When the
realized value of V∞ is v ∈ R8 we let z(γ) and w(γ) denote the realized values
of Z(γ) and W(γ) respectively and in a slight abuse of notation we let
z (a1, x1, x2; γa1,x1,x2) ≡ g (a1, x1) 1va1,x1,x2+γa1,x1,x2>0va1,x1,x2
be the realized value of g(X1, A1)1HT
2,1(V∞+γ)>0
HT2,1V∞ when A1 = a1, X1 = x1
and X2 = x2. Likewise let
w (a1, x1, x2; γa1,x1,x2) ≡ g (a1, x1)
{
1va1,x1,x2+γa1,x1,x2>0 (va1,x1,x2 + γa1,x1,x2)
− 1γa1,x1,x2>0γa1,x1,x2
}
be the realized value of g(X1, A1){[HT2,1(V∞ + γ)]+ − [HT2,1γ]+}.





























[w (a1, x1, x2; γa1,x1,x2)]
Now,
z (a1, x1, x2; γa1,x1,x2) =
{
0 if γa1,x1,x2 ≤ −va1,x1,x2
g (a1, x1) va1,x1,x2 if γa1,x1,x2 > −va1,x1,x2
On the other hand, if va1,x1,x2 > 0 then




0 if γa1,x1,x2 ≤ −va1,x1,x2
g (a1, x1) (va1,x1,x2 + γa1,x1,x2)
if − va1,x1,x2 < γa1,x1,x2 ≤ 0
g (a1, x1) va1,x1,x2 if 0 ≤ γa1,x1,x2
So, if va1,x1,x2 > 0 we conclude that if g(a1, x1) > 0, then supγa1,x1,x2∈R[z(a1, x1,
x2; γa1,x1,x2)] = supγa1,x1,x2∈R[w(a1, x1, x2; γa1,x1,x2)] = g(a1, x1)va1,x1,x2 and if
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g(a1, x1) ≤ 0, then supγa1,x1,x2∈R[z(a1, x1, x2; γa1,x1,x2)] = supγa1,x1,x2∈R[w(a1,
x1, x2; γa1,x1,x2)] = 0.
If va1,x1,x2 ≤ 0 then




0 if γa1,x1,x2 ≤ 0
−g (a1, x1) γa1,x1,x2 if 0 < γa1,x1,x2 ≤ −va1,x1,x2
g (a1, x1) va1,x1,x2 if γa1,x1,x2 > −va1,x1,x2
So, if va1,x1,x2 ≤ 0 we conclude that if g(a1, x1) > 0, then supγa1,x1,x2∈R[z(a1, x1,
x2; γa1,x1,x2)] = supγa1,x1,x2∈R[w(a1, x1, x2; γa1,x1,x2)] = 0 and if g(a1, x1) ≤ 0,
then supγa1,x1,x2∈R[z(a1, x1, x2; γa1,x1,x2)] = supγa1,x1,x2∈R[w(a1, x1, x2;
γa1,x1,x2)] = g(a1, x1)va1,x1,x2 .
We thus conclude that regardless of the values of va1,x1,x2 and g(a1, x1),
it holds that supγa1,x1,x2∈R[z(a1, x1, x2; γa1,x1,x2)] = supγa1,x1,x2∈R[w(a1, x1, x2;
γa1,x1,x2)] and consequently, that supγ∈R8 z(γ) = supγ∈R8 w(γ).
The claim for the equality of the infimums follows by an analogous analysis.
Proof of Part (3). This follows from Parts (1) and (2) of the Lemma and part
(3) of Theorem 4.1 of LLQPM.
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